Selective serotonin reuptake inhibitors affect structure, function and metabolism of skeletal muscle: A systematic review

被引:10
|
作者
Visco, Diego Bulcao [1 ]
Manhaes-de-Castro, Raul [2 ]
Chaves, Wenicios Ferreira [1 ]
Lacerda, Diego Cabral [1 ]
Pereira, Sabrina da Conceicao [3 ]
Ferraz-Pereira, Kelli Nogueira [4 ]
Toscano, Ana Elisa [5 ]
机构
[1] Univ Fed Pernambuco, Postgrad Program Nutr, Recife, PE, Brazil
[2] Univ Fed Pernambuco, Dept Nutr, Recife, PE, Brazil
[3] Univ Fed Pernambuco, Postgrad Program Phys Therapy, Recife, PE, Brazil
[4] Univ Fed Pernambuco, CAV, Dept Phys Educ & Sports Sci, Vitoria De Santo Antao, PE, Brazil
[5] Univ Fed Pernambuco, CAV, Dept Nursing, Rua Alto Reservatorio S-N, BR-55608680 Vitoria De Santo Antao, PE, Brazil
关键词
Serotonin uptake inhibitors; Serotonin; Skeletal muscle; Systematic review; CONGENITAL MYASTHENIC SYNDROME; CUTANEOUS SILENT PERIOD; FLUOXETINE TREATMENT; MYOTONIC-DYSTROPHY; GLUCOSE-METABOLISM; INSULIN-RESISTANCE; NEONATAL TREATMENT; DIABETES-MELLITUS; RAT; ANTIDEPRESSANTS;
D O I
10.1016/j.phrs.2018.09.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Selective Serotonin Reuptake Inhibitors (SSRIs) may have side effects, such as stiffness, tremors and altered tonic activity, as well as an increased risk of developing insulin resistance and diabetes mellitus. However, little is known about the structural, functional and metabolic changes of skeletal muscle after administration of SSRIs. The aim of this systematic review was to explore and discuss the effects of SSRIs on skeletal muscle properties described in human and rodent studies. A systematic search of PUBMED, SCOPUS, and WEB OF SCIENCE was performed. The inclusion criteria were intervention studies in humans and rodents that analysed the effects of SSRIs on skeletal muscle properties. The research found a total of six human studies, including two randomized controlled trials, one non-randomized controlled trial, one uncontrolled before-after study and two case reports, and six preclinical studies in rodents. Overall, the studies in humans and rodents showed altered electrical activity in skeletal muscle function, assessed through electromyography (EMG) and needle EMG in response to chronic treatment or local injection with SSRIs. In addition, rodent studies reported that SSRIs may exert effects on muscle weight, the number of myocytes and the cross-sectional area of skeletal muscle fibre. The results showed effects in energy metabolism associated with chronic SSRI use, reporting altered levels of glycogen synthase activity, acetyl-CoA carboxylase phosphorylation, citrate synthase activity, and protein kinase B Ser phosphorylation. Moreover, changes in insulin signalling and glucose uptake were documented. In this context, we concluded based on human and rodent studies that SSRIs affect electrical muscle activity, structural properties and energy metabolism in skeletal muscle tissue. However, these changes varied according to pre-existing metabolic and functional conditions in the rodents and humans.
引用
收藏
页码:194 / 204
页数:11
相关论文
共 50 条
  • [2] Selective serotonin reuptake inhibitors and cardiovascular events: A systematic review
    Nezafati, Mohammad Hassan
    Eshraghi, Ali
    Vojdanparast, Mohammad
    Abtahi, Saeed
    Nezafati, Pouya
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2016, 21
  • [3] A Systematic Review on the Genotoxic Effects of Selective Serotonin Reuptake Inhibitors
    Ahmadimanesh, Mahnaz
    Abbaszadegan, Mohammad Reza
    Hedayati, Narges
    Yazdian-Robati, Rezvan
    Jamialahmadi, Tannaz
    Sahebkar, Amirhossein
    REVIEWS ON NEW DRUG TARGETS IN AGE-RELATED DISORDERS, PT II, 2021, 1286 : 115 - 124
  • [4] Systematic review and guide to selection of selective serotonin reuptake inhibitors
    Edwards, JG
    Anderson, I
    DRUGS, 1999, 57 (04) : 507 - 533
  • [5] Systematic Review and Guide to Selection of Selective Serotonin Reuptake Inhibitors
    J. Guy Edwards
    Ian Anderson
    Drugs, 1999, 57 : 507 - 533
  • [6] Metabolism and Pharmacokinetics of Selective Serotonin Reuptake Inhibitors
    C. Lindsay DeVane
    Cellular and Molecular Neurobiology, 1999, 19 : 443 - 466
  • [7] Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors
    DeVane, CL
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 1999, 19 (04) : 443 - 466
  • [8] A systematic review and meta-analysis on the effect of selective serotonin reuptake inhibitors on endothelial function
    Delialis, Dimitrios
    Mavraganis, Georgios
    Dimoula, Anna
    Patras, Raphael
    Dimopoulou, Angeliki-Maria
    Sianis, Alexandros
    Ajdini, Erold
    Maneta, Eleni
    Kokras, Nikolaos
    Stamatelopoulos, Kimon
    Georgiopoulos, Georgios
    JOURNAL OF AFFECTIVE DISORDERS, 2022, 316 : 71 - 75
  • [9] A systematic review and meta-analysis on the effect of selective serotonin reuptake inhibitors on endothelial function
    Delialis, D.
    Mavraganis, G.
    Dimoula, A.
    Ajdini, E.
    Bampatsias, D.
    Dimopoulou, A. M.
    Sianis, A.
    Maneta, E.
    Neofytou, O.
    Petropoulos, I.
    Konstantinou, G.
    Misegiannidis, A.
    Kokras, N.
    Stamatelopoulos, K.
    Georgiopoulos, G.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2630 - 2630
  • [10] Alopecia associated with the use of selective serotonin reuptake inhibitors: Systematic review
    Pejcic, Ana V.
    Paudel, Vikash
    PSYCHIATRY RESEARCH, 2022, 313